Mohamed H A Gadelmawla

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 3

Top Topics

Top Venues

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Hany H Arab, Shuruq E Alsufyani, Ahmed M Ashour, Amany M Gad, Alzahraa A Elhemiely, Mohamed H A Gadelmawla, Marwa Ahmed Mahmoud, Ali Khames
Targeting JAK2/STAT3, NLRP3/Caspase-1, and PK2/PKR2 Pathways with Arbutin Ameliorates Lead Acetate-Induced Testicular Injury in Rats. Pharmaceuticals (Basel, Switzerland) 17 (7) (2024)
Hany H Arab, Shuruq E Alsufyani, Ahmed M Ashour, Amany M Gad, Alzahraa A Elhemiely, Mohamed H A Gadelmawla, Marwa Ahmed Mahmoud, Ali Khames
Targeting JAK2/STAT3, NLRP3/Caspase-1, and PK2/PKR2 Pathways with Arbutin Ameliorates Lead Acetate-Induced Testicular Injury in Rats. Pharmaceuticals (Basel, Switzerland) 17 (7) (2024)
Hany H Arab, Shuruq E Alsufyani, Ahmed M Ashour, Amany M Gad, Alzahraa A Elhemiely, Mohamed H A Gadelmawla, Marwa Ahmed Mahmoud, Ali Khames
Targeting JAK2/STAT3, NLRP3/Caspase-1, and PK2/PKR2 Pathways with Arbutin Ameliorates Lead Acetate-Induced Testicular Injury in Rats. Pharmaceuticals (Basel, Switzerland) 17 (7) (2024)